Nur Dikmen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nur Dikmen has a total of 210 co-authors. Here are the top co-authors by number of shared publications:
- Evren Ozcinar
Department of Cardiovascular Surgery, Ankara University, 06100 Ankara, Turkey
20 shared publications - Ahmet Kayan
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, 06340 Ankara, Turkey
10 shared publications - Mehmet Cahit Sarıcaoğlu
Department of Cardiovascular Surgery, Ankara University, 06100 Ankara, Turkey
8 shared publications - Ali Fuat Karacuha
Department of Cardiovascular Surgery, Heart Center, Cebeci Hospitals, Ankara University School of Medicine, Ankara, Turkey
7 shared publications - Cagdas Baran
Ankara University, Turkey (Türkiye)
7 shared publications - Fatma Akça
Kırıkkale High Specialization Hospital
7 shared publications
Latest Publications
- 30 September 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (3) , 292-298
Comparing Reintervention Factors in Acute Deep Vein Thrombosis and Post-Thrombotic Syndrome
Background: Acute iliofemoral deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are characterized by significant morbidity due to impaired venous drainage. Although technical success in endovascular interventions is increasing, the need for reintervention due to complications like stent thrombosis and restenosis remains the primary obstacle to long-term clinical success.Objective: This study aims to compare clinical characteristics and intraoperative findings requiring reintervention in acute DVT and PTS patients to optimize patient-specific follow-up and management strategies.Materials and Methods: We retrospectively evaluated 400 patients (184 Acute DVT, 216 PTS) who underwent iliofemoral venous stenting. A subgroup of 111 patients (51 Acute DVT, 60 PTS) undergoing reintervention for clinical or radiological failure was analyzed. Groups were statistically compared regarding demographics, reintervention indications, and intraoperative findings.Results: The 12-month primary patency rates were 72.5% for Acute DVT and 68.3% for PTS. Among those requiring reintervention, the PTS group had significantly higher rates of recent surgery/trauma (53.3% vs. 27.5%; p=0.010) and recurrent venous ulcers (48.3% vs. 23.5%; p=0.012). Intraoperatively, in-stent restenosis (ISR) was more frequent in the PTS group (66.7% vs. 47.1%; p=0.038). In the Acute DVT group, masked anatomical issues predominated, specifically contralateral outflow obstruction (15.7% vs. 3.3%; p=0.042) and untreated additional venous lesions (47.1% vs. 23.3%; p=0.015). Secondary patency rates remained high in both groups (90.2% and 85.1%).Conclusion: Reintervention etiologies for acute DVT and PTS differ significantly. Failure in PTS is associated with chronic ISR and ulcer recurrence, while missed anatomical lesions during the index procedure are decisive in acute DVT. Extensive anatomical mapping in acute cases and aggressive restenosis monitoring in PTS are critical for long-term success.
- 30 September 2026
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 79 (3) , 292-298
Comparing Reintervention Factors in Acute Deep Vein Thrombosis and Post-Thrombotic Syndrome
Background: Acute iliofemoral deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are characterized by significant morbidity due to impaired venous drainage. Although technical success in endovascular interventions is increasing, the need for reintervention due to complications like stent thrombosis and restenosis remains the primary obstacle to long-term clinical success.Objective: This study aims to compare clinical characteristics and intraoperative findings requiring reintervention in acute DVT and PTS patients to optimize patient-specific follow-up and management strategies.Materials and Methods: We retrospectively evaluated 400 patients (184 Acute DVT, 216 PTS) who underwent iliofemoral venous stenting. A subgroup of 111 patients (51 Acute DVT, 60 PTS) undergoing reintervention for clinical or radiological failure was analyzed. Groups were statistically compared regarding demographics, reintervention indications, and intraoperative findings.Results: The 12-month primary patency rates were 72.5% for Acute DVT and 68.3% for PTS. Among those requiring reintervention, the PTS group had significantly higher rates of recent surgery/trauma (53.3% vs. 27.5%; p=0.010) and recurrent venous ulcers (48.3% vs. 23.5%; p=0.012). Intraoperatively, in-stent restenosis (ISR) was more frequent in the PTS group (66.7% vs. 47.1%; p=0.038). In the Acute DVT group, masked anatomical issues predominated, specifically contralateral outflow obstruction (15.7% vs. 3.3%; p=0.042) and untreated additional venous lesions (47.1% vs. 23.3%; p=0.015). Secondary patency rates remained high in both groups (90.2% and 85.1%).Conclusion: Reintervention etiologies for acute DVT and PTS differ significantly. Failure in PTS is associated with chronic ISR and ulcer recurrence, while missed anatomical lesions during the index procedure are decisive in acute DVT. Extensive anatomical mapping in acute cases and aggressive restenosis monitoring in PTS are critical for long-term success.
- Open Access
- 23 March 2026
- Published by Academician Publishing
Kalp ve Damar Cerrahi - Konjenital Kalp Cerrahisi (Cilt 3)
- 23 March 2026
- Published by Academician Publishing
Open AccessKalp ve Damar Cerrahi - Konjenital Kalp Cerrahisi (Cilt 3)
- 23 March 2026
- Published by Academician Publishing
- p. 1043-1060
Çocuklarda Görülen Kardiyak Tümörler
- 31 December 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (4) , 320-328
Predictors of Mortality Correlated with the SOFA Score in Pediatric VA-ECMO Patients
Background: The objective of this study was to analyze mortality predictors in pediatric VA-ECMO patients, correlating these predictors with the pediatric sequential organ failure assessment score (pSOFA). Aim: To enhance prognostic accuracy and support individualized clinical decision-making by evaluating the correlations between mortality predictors and pediatric sequential organ failure assessment (pSOFA) scores in pediatric VA-ECMO patients. Methods: We conducted a retrospective analysis of 80 consecutive pediatric VA-ECMO cases treated at our center between April 2018 and October 2021. Data collection included patient demographics, clinical features, pSOFA scores, and estimated mortality risks. Survival impacts and morbidity factors were also assessed. The overall decannulation and hospital discharge rates were recorded, with a particular focus on patients with congenital cardiac diseases and those experiencing postcardiotomy low cardiac output, who showed the highest survival rates. Results: Our analysis revealed that certain variables significantly influenced survival outcomes in pediatric VA-ECMO patients. These variables included age, weight, genetic disorders, inotropic support, inhaled nitric oxide (NO) usage, hemodiafiltration, duration of hospital stay, active cardiopulmonary resuscitation during cannulation, and various biochemical markers. Notably, the mean pSOFA scores were significantly lower in survivors compared to non-survivors (9.22 ± 1.43 vs. 13.06 ± 2.69, respectively). Overall decannulation and hospital discharge rates were 60% and 48.75%, respectively, with the highest rates observed in patients with congenital cardiac diseases and postcardiotomy low cardiac output (84.6% and 76.9%, respectively). Furthermore, several mortality predictors were identified, which correlated strongly with pSOFA scores. These predictors included the need for inotropic support, elevated levels of lactate and creatinine, a low protein/albumin ratio, and a low pH prior to cannulation. These findings underscore the critical importance of assessing the severity of organ failure and the overall clinical status when determining mortality risk in pediatric VA-ECMO patients. Conclusion: This study offers valuable insights into the association between pSOFA scores and mortality predictors in pediatric ECMO cases. The significant correlation between higher pSOFA scores and increased mortality highlights the necessity for comprehensive risk assessment and vigilant monitoring of clinical status to optimize patient outcomes. Our findings support the integration of pSOFA scores into routine clinical practice for more effective prognostication and individualized patient management in pediatric VA-ECMO.
- 31 December 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (4) , 320-328
Predictors of Mortality Correlated with the SOFA Score in Pediatric VA-ECMO Patients
Background: The objective of this study was to analyze mortality predictors in pediatric VA-ECMO patients, correlating these predictors with the pediatric sequential organ failure assessment score (pSOFA). Aim: To enhance prognostic accuracy and support individualized clinical decision-making by evaluating the correlations between mortality predictors and pediatric sequential organ failure assessment (pSOFA) scores in pediatric VA-ECMO patients. Methods: We conducted a retrospective analysis of 80 consecutive pediatric VA-ECMO cases treated at our center between April 2018 and October 2021. Data collection included patient demographics, clinical features, pSOFA scores, and estimated mortality risks. Survival impacts and morbidity factors were also assessed. The overall decannulation and hospital discharge rates were recorded, with a particular focus on patients with congenital cardiac diseases and those experiencing postcardiotomy low cardiac output, who showed the highest survival rates. Results: Our analysis revealed that certain variables significantly influenced survival outcomes in pediatric VA-ECMO patients. These variables included age, weight, genetic disorders, inotropic support, inhaled nitric oxide (NO) usage, hemodiafiltration, duration of hospital stay, active cardiopulmonary resuscitation during cannulation, and various biochemical markers. Notably, the mean pSOFA scores were significantly lower in survivors compared to non-survivors (9.22 ± 1.43 vs. 13.06 ± 2.69, respectively). Overall decannulation and hospital discharge rates were 60% and 48.75%, respectively, with the highest rates observed in patients with congenital cardiac diseases and postcardiotomy low cardiac output (84.6% and 76.9%, respectively). Furthermore, several mortality predictors were identified, which correlated strongly with pSOFA scores. These predictors included the need for inotropic support, elevated levels of lactate and creatinine, a low protein/albumin ratio, and a low pH prior to cannulation. These findings underscore the critical importance of assessing the severity of organ failure and the overall clinical status when determining mortality risk in pediatric VA-ECMO patients. Conclusion: This study offers valuable insights into the association between pSOFA scores and mortality predictors in pediatric ECMO cases. The significant correlation between higher pSOFA scores and increased mortality highlights the necessity for comprehensive risk assessment and vigilant monitoring of clinical status to optimize patient outcomes. Our findings support the integration of pSOFA scores into routine clinical practice for more effective prognostication and individualized patient management in pediatric VA-ECMO.
- Open Access
- 20 October 2025
- Published by MDPI AG in Preprints.org
Comparative Outcomes of Catheter-Directed Thrombolysis and Open Surgical Revascularization in Early-Stage Acute Limb Ischemia: Real-World Evidence from a Retrospective Cohort Study
Background: Acute limb ischemia (ALI) is a vascular emergency where timely revascularization is crucial for limb salvage and survival. While open surgical revascularization (OSR) has been the traditional standard, catheter-directed thrombolysis (CDT) has emerged as a minimally invasive alternative. Comparative real-world evidence in early-stage ALI (Rutherford I–IIa) remains limited. Methods: We conducted a retrospective single-center cohort study including 36 patients with ALI treated between 2019 and 2023 (OSR: n=24; CDT: n=12). Demographics, comorbidities, procedural details, and outcomes were analyzed. The primary endpoint was a composite of in-hospital mortality, primary patency, and secondary patency. Secondary endpoints included amputation, cerebrovascular events, renal function, and hospital stay. Effect sizes with 95% confidence intervals were reported alongside p-values to address type II error risk. Results: Baseline characteristics were comparable between groups. Both OSR and CDT significantly improved ankle-brachial index (0.64 ± 0.43 to 0.93 ± 0.33, p< 0.001) and postoperative arterial patency. At 12 months, primary patency was 66.7% (OSR) vs. 50.0% (CDT), and secondary patency was 79.2% vs. 75.0% (p>0.05). Major amputation (12.5% vs. 16.7%) and mortality (8.3% vs. 16.7%) rates did not differ significantly. Hospital stay was longer after OSR (7.29 ± 4.58 vs. 6.08 ± 8.75 days, p=0.038). Fibrinogen levels decreased significantly during CDT, but no major bleeding events occurred. Conclusion: Both OSR and CDT provide effective revascularization in early ALI, with comparable limb salvage and survival outcomes. CDT offers a minimally invasive alternative with acceptable safety when accompanied by careful monitoring, whereas OSR remains a reliable option with immediate reperfusion. Larger multicenter studies are needed to refine patient selection and optimize treatment algorithms.
- 20 October 2025
- Published by MDPI AG in Preprints.org
Open AccessComparative Outcomes of Catheter-Directed Thrombolysis and Open Surgical Revascularization in Early-Stage Acute Limb Ischemia: Real-World Evidence from a Retrospective Cohort Study
Background: Acute limb ischemia (ALI) is a vascular emergency where timely revascularization is crucial for limb salvage and survival. While open surgical revascularization (OSR) has been the traditional standard, catheter-directed thrombolysis (CDT) has emerged as a minimally invasive alternative. Comparative real-world evidence in early-stage ALI (Rutherford I–IIa) remains limited. Methods: We conducted a retrospective single-center cohort study including 36 patients with ALI treated between 2019 and 2023 (OSR: n=24; CDT: n=12). Demographics, comorbidities, procedural details, and outcomes were analyzed. The primary endpoint was a composite of in-hospital mortality, primary patency, and secondary patency. Secondary endpoints included amputation, cerebrovascular events, renal function, and hospital stay. Effect sizes with 95% confidence intervals were reported alongside p-values to address type II error risk. Results: Baseline characteristics were comparable between groups. Both OSR and CDT significantly improved ankle-brachial index (0.64 ± 0.43 to 0.93 ± 0.33, p< 0.001) and postoperative arterial patency. At 12 months, primary patency was 66.7% (OSR) vs. 50.0% (CDT), and secondary patency was 79.2% vs. 75.0% (p>0.05). Major amputation (12.5% vs. 16.7%) and mortality (8.3% vs. 16.7%) rates did not differ significantly. Hospital stay was longer after OSR (7.29 ± 4.58 vs. 6.08 ± 8.75 days, p=0.038). Fibrinogen levels decreased significantly during CDT, but no major bleeding events occurred. Conclusion: Both OSR and CDT provide effective revascularization in early ALI, with comparable limb salvage and survival outcomes. CDT offers a minimally invasive alternative with acceptable safety when accompanied by careful monitoring, whereas OSR remains a reliable option with immediate reperfusion. Larger multicenter studies are needed to refine patient selection and optimize treatment algorithms.
- Open Access
- 10 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6377
Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results
Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.
- 10 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6377
Open AccessTotal Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results
Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.
- Open Access
- 13 August 2025
- Published by MDPI AG in Preprints.org
Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results
Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.
- 13 August 2025
- Published by MDPI AG in Preprints.org
Open AccessTotal Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results
Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.
- Open Access
- 6 March 2025
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 34 (1) , 3-9
Comparison of atherectomy and drug-coated balloon in critical femoropopliteal lesions mid-term results
Aim: Peripheral artery disease (PAD) restricts blood flow to the lower limbs, causing pain, reduced mobility, and critical limb ischemia, leading to severe complications. While atherectomy and drug-coated balloon (DCB) angioplasty are effective revascularization methods, restenosis remains challenging, especially in calcified lesions. This study aims to compare mid-term outcomes, including primary patency, complication rates, and re-intervention needs, between atherectomy combined with DCB angioplasty and DCB-only treatment in patients with femoropopliteal artery disease.Material and Methods: We conducted a retrospective review of 144 PAD patients treated between March 2020 and March 2022. Patients were divided into two groups: 66 received atherectomy plus DCB, while 78 underwent DCB-only angioplasty. Baseline characteristics, lesion parameters, and clinical outcomes, including primary patency and complication rates, were assessed at 6, 12, and 24 months post-procedure using color Doppler ultrasonography (CDUS).Results: At 6 months, patency rates were similar across both groups, but the atherectomy + DCB group showed significantly higher patency at 12 months (p=0.045) and 24 months (p=0.04). Complications, including distal embolism, arterial dissection, and pseudoaneurysm, were comparable between groups. The atherectomy + DCB group also had lower target lesion revascularization rates, suggesting reduced need for re-interventions.Conclusion: Atherectomy combined with DCB angioplasty yields superior mid-term patency compared to DCB alone, especially in patients with calcified lesions. This approach optimizes drug delivery and reduces re-intervention needs, offering a viable option for complex femoropopliteal PAD. Future randomized trials are recommended to confirm these findings and refine patient-specific treatment strategies.
- 6 March 2025
- Published by Damar Cerrahi Dergisi - Turkish Journal of Vascular Surgery in Turkish Journal of Vascular Surgery
- Vol. 34 (1) , 3-9
Open AccessComparison of atherectomy and drug-coated balloon in critical femoropopliteal lesions mid-term results
Aim: Peripheral artery disease (PAD) restricts blood flow to the lower limbs, causing pain, reduced mobility, and critical limb ischemia, leading to severe complications. While atherectomy and drug-coated balloon (DCB) angioplasty are effective revascularization methods, restenosis remains challenging, especially in calcified lesions. This study aims to compare mid-term outcomes, including primary patency, complication rates, and re-intervention needs, between atherectomy combined with DCB angioplasty and DCB-only treatment in patients with femoropopliteal artery disease.Material and Methods: We conducted a retrospective review of 144 PAD patients treated between March 2020 and March 2022. Patients were divided into two groups: 66 received atherectomy plus DCB, while 78 underwent DCB-only angioplasty. Baseline characteristics, lesion parameters, and clinical outcomes, including primary patency and complication rates, were assessed at 6, 12, and 24 months post-procedure using color Doppler ultrasonography (CDUS).Results: At 6 months, patency rates were similar across both groups, but the atherectomy + DCB group showed significantly higher patency at 12 months (p=0.045) and 24 months (p=0.04). Complications, including distal embolism, arterial dissection, and pseudoaneurysm, were comparable between groups. The atherectomy + DCB group also had lower target lesion revascularization rates, suggesting reduced need for re-interventions.Conclusion: Atherectomy combined with DCB angioplasty yields superior mid-term patency compared to DCB alone, especially in patients with calcified lesions. This approach optimizes drug delivery and reduces re-intervention needs, offering a viable option for complex femoropopliteal PAD. Future randomized trials are recommended to confirm these findings and refine patient-specific treatment strategies.
- Open Access
- 20 November 2024
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 3 (4) , 471-479
Evaluating the Efficacy and Safety of Transbrachial Access in Iliac Endovascular Interventions: A Comprehensive Analysis
Background: This study evaluates the use of transbrachial artery access for endovascular treatment of iliac artery lesions, with a focus on its efficacy and safety outcomes. Methods: Between January 2020 and May 2023, 94 patients with iliac artery disease underwent endovascular procedures via a transbrachial access approach. The majority of patients (n = 68; 72%) presented with lifestyle-limiting claudication (Rutherford category 3). Diagnostic angiography identified Transatlantic Inter-Society Consensus II (TASC) C/D lesions in 54 patients (57%). The primary outcome was achieving technical success with transbrachial access, while secondary outcomes included secondary technical success (necessitating additional transfemoral access), access site complications, and cerebrovascular events. Results: The primary and secondary technical success rates were 82% and 92%, respectively. Access site-related adverse events occurred in 12 patients (12%), primarily hematomas (seven events, 7.4%; two requiring transfusion) and pseudoaneurysms (four events, 4.2%). Thrombotic occlusion was observed in one patient (1%), and brachial arterial bleeding requiring urgent surgical intervention occurred in three patients (3.2%). Neurological complications included two cerebrovascular events (2.1%), although no permanent or transient median nerve injuries were observed. Conclusions: The transbrachial approach represents a potential alternative to the femoral artery route in patients with iliac artery lesions. However, the relatively higher incidence of access site complications may limit its broader application in clinical practice.
- 20 November 2024
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 3 (4) , 471-479
Open AccessEvaluating the Efficacy and Safety of Transbrachial Access in Iliac Endovascular Interventions: A Comprehensive Analysis
Background: This study evaluates the use of transbrachial artery access for endovascular treatment of iliac artery lesions, with a focus on its efficacy and safety outcomes. Methods: Between January 2020 and May 2023, 94 patients with iliac artery disease underwent endovascular procedures via a transbrachial access approach. The majority of patients (n = 68; 72%) presented with lifestyle-limiting claudication (Rutherford category 3). Diagnostic angiography identified Transatlantic Inter-Society Consensus II (TASC) C/D lesions in 54 patients (57%). The primary outcome was achieving technical success with transbrachial access, while secondary outcomes included secondary technical success (necessitating additional transfemoral access), access site complications, and cerebrovascular events. Results: The primary and secondary technical success rates were 82% and 92%, respectively. Access site-related adverse events occurred in 12 patients (12%), primarily hematomas (seven events, 7.4%; two requiring transfusion) and pseudoaneurysms (four events, 4.2%). Thrombotic occlusion was observed in one patient (1%), and brachial arterial bleeding requiring urgent surgical intervention occurred in three patients (3.2%). Neurological complications included two cerebrovascular events (2.1%), although no permanent or transient median nerve injuries were observed. Conclusions: The transbrachial approach represents a potential alternative to the femoral artery route in patients with iliac artery lesions. However, the relatively higher incidence of access site complications may limit its broader application in clinical practice.
- Open Access
- 1 November 2024
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 32 (4) , 61-62
[MSB-36] Long-Term Results of Covered Endovascular Aortic Bifurcation Repair in Complex Aortoiliac Disease: A Two-Year Follow-Up
Objective: This study aimed to investigate the two-year outcomes of covered endovascular reconstruction of the aortic bifurcation (CERAB) in patients with complex aortoiliac occlusive disease. Methods: This retrospective study was conducted with 40 patients (33 males, 7 females) with aortoiliac occlusive disease categorized as TASC (Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease) II B, C, and D, based on computed tomography angiography findings. All patients underwent the CERAB procedure. The study assessed procedural outcomes, including clinical and symptomatic improvements, as well as patency rates, over a two-year follow-up period. Results: The technical success rate was 100% across all procedures. At 36 months, the overall primary patency, assisted primary patency, and secondary patency rates were 85%, 90%, and 92.5%, respectively. Conclusions: The two-year outcomes of this study suggest that CERAB offers patency rates comparable to those reported in other studies for complex aortoiliac occlusive diseases. The procedure showed favorable patency rates, particularly for more advanced TASC II B, C, and D lesions.
- 1 November 2024
- Published by Galenos Yayinevi in Turkish Journal of Thoracic and Cardiovascular Surgery
- Vol. 32 (4) , 61-62
Open Access[MSB-36] Long-Term Results of Covered Endovascular Aortic Bifurcation Repair in Complex Aortoiliac Disease: A Two-Year Follow-Up
Objective: This study aimed to investigate the two-year outcomes of covered endovascular reconstruction of the aortic bifurcation (CERAB) in patients with complex aortoiliac occlusive disease. Methods: This retrospective study was conducted with 40 patients (33 males, 7 females) with aortoiliac occlusive disease categorized as TASC (Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease) II B, C, and D, based on computed tomography angiography findings. All patients underwent the CERAB procedure. The study assessed procedural outcomes, including clinical and symptomatic improvements, as well as patency rates, over a two-year follow-up period. Results: The technical success rate was 100% across all procedures. At 36 months, the overall primary patency, assisted primary patency, and secondary patency rates were 85%, 90%, and 92.5%, respectively. Conclusions: The two-year outcomes of this study suggest that CERAB offers patency rates comparable to those reported in other studies for complex aortoiliac occlusive diseases. The procedure showed favorable patency rates, particularly for more advanced TASC II B, C, and D lesions.